| 2005 |
Irx5 represses Kv4.2 (Kcnd2) potassium-channel gene expression in endocardial myocardium by recruiting mBop (a cardiac transcriptional repressor), establishing an inverse Ito,f gradient that ensures coordinated cardiac ventricular repolarization and prevents arrhythmias. |
Irx5 knockout mice, chromatin co-IP (recruitment of mBop), electrophysiology (Ito,f measurement), immunofluorescence gradient analysis |
Cell |
High |
16239150
|
| 2005 |
Irx5 is expressed in a subset of cone bipolar cells in the mature mouse retina (Type 2 and Type 3 OFF cone bipolar cells) starting at postnatal day 5, and is required for their differentiation independently of the Vsx1 pathway, as Irx5-deficient mice lack certain bipolar cell markers while Vsx1 expression is unaffected. |
Irx5 knockout mice, immunohistochemistry with cell-type specific markers, genetic epistasis (Irx5/Vsx1 double mutant analysis) |
Developmental biology |
High |
16182275
|
| 2008 |
Vsx1 and Irx5 together control response threshold, gain, range, and contrast adaptation specifically in OFF (not ON) retinal ganglion cell circuits, demonstrated by loss-of-function in Vsx1−/−Irx5−/− double-mutant mice; bipolar cell morphology was normal but OFF circuit function was selectively impaired. |
Vsx1/Irx5 double knockout mice, multi-electrode array retinal ganglion cell recording, linear-nonlinear model of contrast adaptation |
The Journal of neuroscience |
High |
18322081
|
| 2012 |
Irx5 modulates migration of progenitor cell populations in branchial arches and gonads by repressing Sdf1 expression; transcriptional control by Irx5 is modulated by direct protein-protein interaction with GATA3 and TRPS1 zinc-finger proteins. |
In vivo modeling in Xenopus laevis embryos (loss-of-function), protein-protein interaction assays, homozygosity mapping in human patients with IRX5 mutations |
Nature genetics |
High |
22581230
|
| 2012 |
Irx3 and Irx5 have redundant function in the endocardium to regulate atrioventricular canal morphogenesis and outflow tract formation via direct transcriptional repression of Bmp10; combined postnatal loss of Irx3 and Irx5 in the myocardium activates Nav1.5 expression and prolongs atrioventricular conduction; postnatal Irx5 can repress Irx3 activity, as combined loss restores the repolarization gradient lost in Irx5-single mutants. |
Irx3/Irx5 double knockout and conditional knockout mice, RT-PCR, electrophysiology, genetic epistasis |
Development (Cambridge, England) |
High |
22992950
|
| 2021 |
IRX5 forms a transcription factor complex with GATA4 in cardiac cells, in which IRX5 potentiates GATA4-induction of SCN5A (Nav1.5) expression; loss-of-function mutations in IRX5 in human hiPSC-derived cardiomyocytes reduce Nav1.5 and Cx40 expression and slow ventricular action potential depolarization due to reduced sodium current. |
hiPSC-derived cardiomyocytes from Hamamy syndrome patients with IRX5 loss-of-function mutations, electrophysiology (patch clamp), Co-IP (IRX5-GATA4 complex identification), transcriptomic analysis |
Cardiovascular research |
High |
32898233
|
| 2003 |
Irx5 is a direct, positively regulated downstream transcriptional target of Hoxb4. |
Chick embryo gain-of-function experiments, reporter assays demonstrating direct transcriptional regulation |
Developmental dynamics |
Medium |
12701098
|
| 2018 |
IRX5 promotes proliferation, migration, and invasion of tongue squamous cell carcinoma cells by directly targeting the osteopontin (OPN) promoter and activating the NF-κB pathway. |
Gain- and loss-of-function in CAL27 cells, promoter binding assays, xenograft tumor model, Western blot |
Journal of cellular and molecular medicine |
Medium |
29761910
|
| 2018 |
IRX5 regulates adipocyte amyloid precursor protein (APP) expression by increasing APP promoter activity; both IRX5 and APP inhibit transactivation of PGC-1α and UCP1; knockdown of Irx5 or App increases mitochondrial respiration in adipocytes; Irx5 knockout mice are protected from diet-induced fat accumulation with upregulated Pgc-1α and Ucp1. |
Irx5 knockout mice (HF diet model), stable Irx5 knockdown in adipocytes, transcriptome analysis, transcriptional activation assays (APP promoter-luciferase), Seahorse metabolic assay |
International journal of obesity |
Medium |
30538277
|
| 2019 |
IRX5 promotes colorectal cancer cell migration and invasion by inhibiting the core components of the RHOA/ROCK1/LIMK1 signaling pathway; overexpression of LIMK1 reverses the enhanced cellular motility caused by IRX5 overexpression. |
IRX5 overexpression/knockdown in CRC cells, migration/invasion assays, rescue with LIMK1 overexpression, in vivo nude mouse metastasis model |
Molecular carcinogenesis |
Medium |
31432570
|
| 2016 |
IRX5 promotes G1/S-phase transition in vascular smooth muscle cells (VSMCs) via CDK2-dependent activation; Irx5 gain- and loss-of-function modulates DNA synthesis and regulates expression of p27(kip1), E2F1, and PCNA; IRX5 overexpression also induces apoptosis via caspase-3 activation; Irx5 expression is elevated in vivo in balloon-injured rat carotid arteries. |
Thymidine/BrdU incorporation assays in primary rat aortic VSMCs, RT-PCR, immunohistochemistry of injured arteries, caspase-3 activation assay |
American journal of physiology. Cell physiology |
Medium |
27170637
|
| 2018 |
During follicle development, Irx3 and Irx5 are colocalized in pre-granulosa cells; Irx5 transitions to granulosa cell-specific expression during primordial follicle formation. Loss of both Irx3 and Irx5 causes defects in granulosa cell basement membrane deposition, mis-localization of gap junction proteins, and fewer cell projections, compromising granulosa cell-oocyte communication. |
Multiple Irx3/Irx5 mutant mouse models, reporter mice for lineage tracing, immunofluorescence, histology |
PLoS genetics |
Medium |
30071018
|
| 2020 |
Canonical Wnt/β-catenin signaling directly stimulates Irx3 and Irx5 transcription in the developing ovary through TCF/LEF-binding sequences in two distal enhancers of the IrxB locus; in the developing testis, these same sites carry H3K27me3 marks that suppress Irx3 and Irx5 transcription. |
ATAC-seq and ChIP-seq database analysis, mouse gonad explant transfection/reporter assays, β-catenin gain/loss-of-function in gonads |
Development (Cambridge, England) |
Medium |
32108023
|
| 2020 |
IRX3 and IRX5 inhibit adipogenic differentiation of hypertrophic chondrocytes and promote their transition to osteoblasts; this function is downstream of WNT/β-catenin signaling, as β-catenin gain- and loss-of-function in hypertrophic chondrocytes affects Irx3 and Irx5 expression. |
Irx3/Irx5 single and compound null mutant mice, lineage tracing, bone histomorphometry, micro-CT, β-catenin conditional KO and gain-of-function in hypertrophic chondrocytes |
Journal of bone and mineral research |
Medium |
32662900
|
| 2021 |
Irx3 and Irx5 regulate postnatal hypothalamic neurogenesis from a radial glia-like neural stem cell (RGL-NSC) population; reduced Irx3/Irx5 dosage promotes neurogenesis leading to elevated numbers of leptin-sensing arcuate neurons, resulting in enhanced leptin response and lower food intake. |
Irx3/Irx5 double heterozygous mice, Ins2-Cre lineage tracing, single-cell RNA sequencing, leptin response assays, food intake measurement |
Nature metabolism |
High |
33859429
|
| 2021 |
Irx3 and Irx5 are ectopically expressed in Sim1+ PVH neurons of Sim1+/− mice; reducing Irx3/Irx5 dosage or PVH-specific deletion of Irx3 rescues PVH neuron defects and hyperphagia in Sim1+/− mice, demonstrating that misexpression of Irx3 and Irx5 is a central mechanism disrupting PVH development and feeding regulation in Sim1 haploinsufficiency. |
Single-cell RNA sequencing, Irx3/Irx5 dosage reduction in Sim1+/− mice, PVH-specific conditional Irx3 deletion, food intake measurement |
Science advances |
Medium |
34705510
|
| 2022 |
Irx5 is a vital transcription factor that establishes transmural heterogeneity of ventricular myocyte contractility by regulating Ito,f gradients (via Kcnd2 and Kcnip2 expression specifically in endocardium); Irx5-KO mice show decreased global LV contractility and reduced cell shortening/Ca2+ transients in endocardial but not epicardial cardiomyocytes; double KO of Irx5 and Kcnd2 restores contractility to KV4.2-KO levels, demonstrating dominant role of Irx5-dependent Ito,f. |
Irx5-KO, KV4.2-KO, and Irx5/KV4.2 double-KO mice, isolated cardiomyocyte contractility/Ca2+ measurements, transcriptional profiling, echocardiography |
American journal of physiology. Heart and circulatory physiology |
High |
35245131
|
| 2022 |
IRX5 promotes adipogenesis of human bone marrow-derived mesenchymal stem cells (hMSCs) by transcriptionally activating PGC-1α and inhibiting glycolysis; metformin and PGC-1α inhibitor reverse IRX5-induced adipogenesis. |
Lentiviral IRX5 gain/loss-of-function in hMSCs, RNA-seq, metabolomics, dual-luciferase reporter assay (PGC-1α promoter), adipogenesis assays |
Cell death discovery |
Medium |
35428362
|
| 2022 |
Irx5 deficiency in mice protects against diet-induced obesity primarily through increased adipose thermogenesis (upregulation of PGC-1α and UCP1) and improved hypothalamic leptin response; scRNA-seq of the arcuate-median eminence region shows elevated neuron numbers in Irx5KO mice. |
Irx5 knockout mice on high-fat diet, body composition measurement, energy expenditure assays, scRNA-seq of hypothalamic ARC-ME region |
International journal of obesity |
Medium |
36115924
|
| 2023 |
IRX5 promotes DNA damage repair and hair follicle stem cell (HFSC) activation; Irx5-/- mice show delayed anagen onset, increased DNA damage, diminished HFSC proliferation, and open chromatin near cell cycle and DNA damage repair genes; BRCA1 is an IRX5 downstream transcriptional target; Irx5-/- quiescence is partly due to failure to suppress Fgf18, as FGF kinase signaling inhibition partially rescues the anagen delay. |
Irx5-/- mice, ATAC-seq of HFSCs, ChIP/reporter assays for BRCA1 as downstream target, pharmacological rescue with FGF kinase inhibitor, proliferation/DNA damage assays |
Stem cell reports |
Medium |
37084727
|
| 2018 |
IRX3 and IRX5 are essential for mammalian nephrogenesis; in Wilms tumour, IRX5 expression is activated in early proliferative blastema and IRX5-/- Wilms tumour cells activate Hippo and non-canonical WNT signaling, generating small tumours with abundant tubulogenesis. |
Irx3-/Irx5- double knockout mice (embryonic nephron formation), orthotopic xenograft mouse model with IRX3-/- and IRX5-/- Wilms tumour cells, pathway analysis |
The Journal of pathology |
Medium |
30246301
|
| 2018 |
Id2 represses Irx5 in the midgut endoderm to establish intestinal identity; transgenic mice expressing Irx5 in midgut endoderm develop gastric metaplasia-like intestinal tumors, recapitulating the Id2-/- phenotype. |
Id2-/- mice, Irx5 transgenic mice with midgut-specific expression, gene expression analysis, histology |
Molecular and cellular biology |
Medium |
29463648
|
| 2024 |
IRX5 interacts directly with HMGN4; HMGN4 drives IRX5 nuclear translocation and co-localizes with IRX5 in the nucleus; IRX5 promotes de novo fatty acid synthesis in hepatocellular carcinoma, accelerating cancer cell proliferation and progression. |
GST pull-down combined with GC/MS, co-immunoprecipitation, immunofluorescence co-localization, HMGN4 overexpression effects on IRX5 nuclear transport |
Journal of cellular and molecular medicine |
Medium |
40208102
|
| 2024 |
IRX5 suppresses osteogenic differentiation of human BMSCs by inhibiting mTOR-mediated ribosomal translation and impairing mitochondrial oxidative phosphorylation; mTOR activator MHY1485 reverses the inhibitory impact of IRX5 on osteogenesis. |
IRX5 gain/loss-of-function in hBMSCs, RNA-seq, transmission electron microscopy, Seahorse mito-stress assay, Surface Sensing of Translation (SUnSET) assay, pharmacological rescue with mTOR activator |
Journal of cellular physiology |
Medium |
38666481
|
| 2024 |
IRX5 transcriptionally regulates YWHAB (14-3-3β) expression by acting on its promoter sequence upstream of the transcription start site, as demonstrated by dual luciferase assay. |
Dual luciferase reporter assay, gain/loss-of-function in breast cancer cells |
Oncology letters |
Low |
39119237
|
| 2026 |
PLAGL1 transcriptionally activates Irx5 synergistically with KLF4 in periosteal stem/progenitor cells (PSPCs), and IRX5 in turn induces downstream osteogenic genes; this PLAGL1-KLF4-IRX5 axis controls osteoblast differentiation of PSPCs during mandibular bone regeneration. |
PLAGL1 KO mice, CRISPR-dCas9-Tet1 epigenetic activation system, transcriptional reporter assays, mandible regeneration model |
Nature communications |
Medium |
42168182
|